You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma
|
|---|---|
| Published in |
JAMA Oncology, April 2024
|
| DOI | 10.1001/jamaoncol.2023.6789 |
| Pubmed ID | |
| Authors |
Peter W. Szlosarek, Benjamin C. Creelan, Thomas Sarkodie, Luke Nolan, Paul Taylor, Olga Olevsky, Federica Grosso, Diego Cortinovis, Meenali Chitnis, Amy Roy, David Gilligan, Hedy Kindler, Dionysis Papadatos-Pastos, Giovanni L. Ceresoli, Aaron S. Mansfield, Anne Tsao, Kenneth J. O’Byrne, Anna K. Nowak, Jeremy Steele, Michael Sheaff, Chiung-Fang Shiu, Chih-Ling Kuo, Amanda Johnston, John Bomalaski, Marjorie G. Zauderer, Dean A. Fennell, Igor I. Rybkin, Christian D. Rolfo, Melanie MacKean, Nicola Steele, Kevin Franks, Paul Shaw, Michael J. Lind, Sunil Upadhyay, Thomas John, Christos Karapetis, Ratnesh Srivastav, Manlio Mencoboni, Antonio Chella, Nicoletta Zilembo, Filippo de Marinis, Maria Giulia Stella, Inn-Wen Chong, Chin-Chou Wang |
X Demographics
The data shown below were collected from the profiles of 41 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 20% |
| France | 8 | 20% |
| India | 2 | 5% |
| Colombia | 2 | 5% |
| Argentina | 1 | 2% |
| Mexico | 1 | 2% |
| Brazil | 1 | 2% |
| Italy | 1 | 2% |
| Saudi Arabia | 1 | 2% |
| Other | 3 | 7% |
| Unknown | 13 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 24 | 59% |
| Practitioners (doctors, other healthcare professionals) | 11 | 27% |
| Scientists | 6 | 15% |
Mendeley readers
The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 5 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 2 | 40% |
| Researcher | 1 | 20% |
| Unspecified | 1 | 20% |
| Unknown | 1 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 1 | 20% |
| Computer Science | 1 | 20% |
| Agricultural and Biological Sciences | 1 | 20% |
| Sports and Recreations | 1 | 20% |
| Medicine and Dentistry | 1 | 20% |
| Other | 0 | 0% |
Attention Score in Context
This research output has an Altmetric Attention Score of 503. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2024.
All research outputs
#52,471
of 25,822,778 outputs
Outputs from JAMA Oncology
#98
of 3,369 outputs
Outputs of similar age
#393
of 194,406 outputs
Outputs of similar age from JAMA Oncology
#3
of 93 outputs
Altmetric has tracked 25,822,778 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,369 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 84.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,406 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.